Update to guidance on protocol deviation submissions
The guidance on protocol deviation submissions has been updated to include a new item:
For-Cause audit reports and findings, and other site or study audits by a regulatory agency such as the FDA where serious or significant adverse findings are reported. In all cases, a Corrective Action Plan should also be submitted for review.
This will be updated to be included in the form itself in ERM in a future update.